Article: Generics are in midst of a golden age ... for now.(Focus)

Article: Boca appoints Gunter to head generics sales.(RX ...
Chain Drug Review;  July 24, 2006 ;     691 words ...COCONUT CREEK, Fla. -- Sara Gunter has joined Boca Pharmacal Inc. as vice president of generics sales. She has nearly 20 years of generic drug marketing experience. Most recently Gunter served as vice president of client relationship ...

Article: Generics sales bounce back. (generic drugs)
Chain Drug Review;  February 24, 1992 ;     700+ words ...NEW YORK--In August 1989 the Food and Drug Administration's acting associate commissioner for regulatory affairs, Ronald Chesemore, ordered a survey of generic drugs in all 50 states. This survey identified several significant drawbacks in the generic drug industry and regulatory processes that

Article: Strong generics sales see profit soar for ...
Pharma Marketletter;  May 11, 2009 ;     563 words ...US drugmaker IMPAX Laboratories' profit rocketed for the first quarter of 2009, compared to the same period of the year before, due to growing copy-drug sales. The firm's net income reached $2.2 million, or $0.04 per share, versus just $460,000, or $0.01 per share. As of March 31, the firm had

Article: Spanish generics sales up 19% in 2004.(Brief ...
Pharma Marketletter;  April 4, 2005 ;     700+ words ...Spain's generic drug market increased 19% by value last year, to reach 410.0 million euros ($359.4 million), aided by government efforts to promote and develop the drugs. The Aeseg, the national association representing the largest generics manufacturers, says that it welcomes the government

Article: Global generics sales may hit $80 billion by ...
Chain Drug Review;  July 19, 2004 ;     700+ words ...PRAGUE -- Worldwide generic drug sales could soar to as much as $80 billion by 2008, according to IMS Health, which predicts that such sales will increase by more than 20% a year, compared with a growth rate of less than half that percentage in the branded sector. As has been the case in the United

Article: Japan's generics sales up 2.9%, but slowing.
Pharma Marketletter;  September 8, 2008 ;     514 words ...Turnover of generic drugs in Japan for the 2007 fiscal year were worth 360.0 billion yen ($3.31 billion), a rise of 2.9% on the prior 12 months, but the advance was much lower than the 13% increase registered then, reports the Nikkei Weekly. Slower growth is forecast for this year. The country's

Article: Ciba melds branded, generics sales units. ...
Chain Drug Review;  March 13, 1995 ;     679 words ...Summit, N.J. - A combined business that company officials say ranks second in prescription drugs dispensed has been formed in CibaGeneva Pharmaceuticals. The alliance brings together the sales and marketing organizations of the branded business of Ciba Pharmaceuticals Inc. Both are units of